Related Experiment Video
Updated: Jun 9, 2025
05:38
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
Published on: January 7, 2019
17.8K
Rare but relevant: Methamphetamine and Parkinson's disease
1National Drug and Alcohol Research Centre (NDARC), University of New South Wales, Sydney, Australia.
Addiction (Abingdon, England)
|October 22, 2024
Summary
Methamphetamine use increases the risk of developing Parkinson's disease (PD) and parkinsonism. However, PD is underdiagnosed in users due to factors like mortality and smoking, necessitating clinical vigilance.
Area of Science:
- Neuroscience
- Toxicology
- Epidemiology
Background:
- Methamphetamine (MA) use is linked to a higher risk of Parkinson's disease (PD) and parkinsonism.
- Animal studies suggest biological mechanisms supporting this association.
- The prevalence of PD and parkinsonism is elevated in current and former MA users.
Purpose of the Study:
- To explore the relationship between methamphetamine use and Parkinson's disease.
- To investigate reasons for the underdiagnosis of PD in methamphetamine users.
Main Methods:
- Review of existing evidence from various research paradigms.
- Analysis of prevalence data in methamphetamine user populations.
- Consideration of potential moderating factors and biological plausibility.
Main Results:
- Methamphetamine use is associated with increased risk and premature onset of PD and parkinsonism.
- PD is infrequently diagnosed in methamphetamine users, suggesting underdetection.
- Factors like premature mortality, smoking, and other individual characteristics may influence risk and detection.
Conclusions:
- Clinicians must maintain a high index of suspicion for PD and parkinsonism in methamphetamine users.
- Further research is needed to understand the complex interplay of factors affecting PD diagnosis in this population.
Related Concept Videos
01:24Parkinson's Disease: Treatment
227
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
227
01:15Parkinson's Disease: Overview
486
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
486
01:29Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
165
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
165
01:37Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
01:15Drug Abuse and Addiction: Pharmacological Phenomena
445
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
445